JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:700-707, doi:10.1016/j.jacc.2006.04.083 (Published online 21 July 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.04.083v1
48/4/700    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riksen, N. P.
Right arrow Articles by Rongen, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riksen, N. P.
Right arrow Articles by Rongen, G. A.

CLINICAL RESEARCH: ISCHEMIC PRECONDITIONING

Caffeine Prevents Protection in Two Human Models of Ischemic Preconditioning

Niels P. Riksen, MD*,{dagger},*, Zhigang Zhou, MD*, Wim J.G. Oyen, MD, PhD{ddagger}, Rogier Jaspers, MD§, Bart P. Ramakers, MSc*, Rene M.H.J. Brouwer, MD, PhD§, Otto C. Boerman, PhD{ddagger}, Neil Steinmetz, MD, PhD||, Paul Smits, MD, PhD*,{dagger} and Gerard A. Rongen, MD, PhD*,{dagger}

* Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
{dagger} Department of Internal Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
{ddagger} Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
§ Department of Cardiothoracic Surgery, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
|| North American Scientific, Theseus Imaging Division, Boston, Massachusetts.

Manuscript received February 15, 2006; revised manuscript received April 4, 2006, accepted April 10, 2006.

* Reprint requests and correspondence: Dr. Niels P. Riksen, Department of Pharmacology-Toxicology 149, Radboud University Nijmegen Medical Center, Geert Grooteplein 21, 6525 EZ Nijmegen, the Netherlands. (Email: N.Riksen{at}aig.umcn.nl).

OBJECTIVES: We studied whether caffeine impairs protection by ischemic preconditioning (IP) in humans.

BACKGROUND: Ischemic preconditioning is critically dependent on adenosine receptor stimulation. We hypothesize that the adenosine receptor antagonist caffeine blocks the protective effect of IP.

METHODS: In vivo ischemia-reperfusion injury was assessed in the thenar muscle by 99mTc-annexin A5 scintigraphy. Forty-two healthy volunteers performed forearm ischemic exercise. In 24 subjects, this was preceded by a stimulus for IP. In a randomized double-blinded design, the subjects received caffeine (4 mg/kg) or saline intravenously before the experiment. At reperfusion, 99mTc-annexin A5 was administered intravenously. Targeting of annexin was quantified by region-of-interest analysis, and expressed as percentage difference between experimental and contralateral hand. In vitro, we assessed recovery of contractile function of human atrial trabeculae, harvested during heart surgery, as functional end point of ischemia-reperfusion injury. Field-stimulated contraction was quantified at baseline and after simulated ischemia-reperfusion, in a paired approach with and without 5 min of IP, in the presence (n = 13) or absence (n = 17) of caffeine (10 mg/l).

RESULTS: Ischemic preconditioning reduced annexin targeting in the absence of caffeine (from 13 ± 3% to 7 ± 1% at 1 h, and from 19 ± 2% to 9 ± 3% at 4 h after reperfusion, p = 0.006), but not after caffeine administration (targeting 11 ± 2% and 16 ± 3% at 1 and 4 h). In vitro, IP improved post-ischemic functional recovery in the control group, but not in the caffeine group (8 ± 3% vs. –8 ± 5%, p = 0.003).

CONCLUSIONS: Caffeine abolishes IP in 2 human models at a dose equivalent to the drinking of 2 to 4 cups of coffee. (The Effect of Caffeine on Ischemic Preconditioning; http://clinicaltrials.gov/ct/show/NCT00184912?order=1; NCT00184912 [ClinicalTrials.gov] ).

Abbreviations and Acronyms
  IP = ischemic preconditioning
  Isch Ex = ischemic exercise




This article has been cited by other articles:


Home page
JNMHome page
F. G. Blankenberg
In Vivo Detection of Apoptosis
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 81S - 95S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. P. Riksen, B. Franke, W. J.G. Oyen, G. F. Borm, P. van den Broek, O. C. Boerman, P. Smits, and G. A. Rongen
Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene
Eur. Heart J., May 1, 2007; 28(9): 1085 - 1091.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.